Christophe M. Bianchi
President bei Millennium Pharmaceuticals, Inc.
Profil
Christophe M.
Bianchi is currently the President-Global Oncology Business Unit at Millennium Pharmaceuticals, Inc. He previously held the position of President & Director at ARIAD Pharmaceuticals, Inc. and Director at Penwest Pharmaceuticals Co. Prior to that, he was the Vice President-Global Marketing at Rhone-Poulenc Rorer, Inc. from 1989 to 1999.
From 2001 to 2006, he served as the Head-US Oncology Business Unit at Sanofi-Aventis U.S.
LLC.
Additionally, he was the President-Europe & SVP-Global Marketing at Sangstat Pharmaceuticals Corp.
from 2000 to 2001.
Dr. Bianchi holds an MBA from the University of Pennsylvania, a doctorate from Université de Technologie de Compiègne, and an undergraduate degree from HEC Montréal.
Aktive Positionen von Christophe M. Bianchi
Unternehmen | Position | Beginn |
---|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | President | - |
Ehemalige bekannte Positionen von Christophe M. Bianchi
Unternehmen | Position | Ende |
---|---|---|
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01.01.2006 |
Sangstat Pharmaceuticals Corp. | Sales & Marketing | 01.01.2001 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Sales & Marketing | 01.01.1999 |
ARIAD PHARMACEUTICALS, INC. | President | - |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Director/Board Member | - |
Ausbildung von Christophe M. Bianchi
University of Pennsylvania | Masters Business Admin |
Université de Technologie de Compiègne | Doctorate Degree |
HEC Montréal | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
Sangstat Pharmaceuticals Corp. |